CITR CitroTech Inc.
Chemicals & Allied Products · NYSE · SEC CIK 894556 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-14.3%
TTM net income YoY43.2%
TTM EPS YoY78.7%
Revenue 3-yr CAGR87.7%
Net income 3-yr CAGR—
Margins
Gross margin23.6%
Operating margin-927.5%
Net margin-1,071.4%
FCF margin-447.2%
EBITDA margin-901.0%
Returns
ROE-235.3%
ROA-177.7%
ROIC (approx.)-293.9%
Asset turnover0.17x
Leverage & solvency
Liabilities / assets15.7%
Debt / equity0.00x
Current ratio2.99x
Interest coverage-44.68x
Cash quality & payout
Operating cash flow / net income0.42x
Accruals ratio-103.5%
Payout ratio—
Capex / revenue-0.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $2.38M | $808,372 | $520,645 | $62,732 | $0 |
| Cost of revenue | $1.85M | $655,499 | $182,730 | $56,338 | $18,613 |
| Gross profit | $530,725 | $152,873 | $387,137 | $60,839 | $20,306 |
| R&D expense | $198,505 | $14,002 | $0 | — | — |
| SG&A expense | $1.59M | $498,445 | $256,602 | $256,686 | $3,672 |
| Operating income | -$16.50M | -$5.30M | -$10.10M | -$2.92M | -$37,909 |
| Interest expense | $1.51M | $257,782 | $4,328 | $255 | $1,469 |
| Pretax income | -$36.84M | -$6.88M | -$10.10M | -$2.92M | -$44,973 |
| Income tax | $0 | $0 | $0 | $0 | $0 |
| Net income | -$36.84M | -$6.88M | -$10.10M | -$2.91M | -$94,973 |
| EBITDA | -$16.17M | -$5.04M | -$9.85M | -$2.90M | -$28,172 |
| EPS (basic) | -2.96 | -0.82 | -0.10 | -0.05 | 0.00 |
| EPS (diluted) | -2.96 | -0.82 | -0.10 | 0.00 | 0.00 |
| Weighted avg. shares (diluted) | 12.44M | 8.38M | 96.66M | 75.27M | 22.95M |
| Balance sheet | |||||
| Cash & equivalents | $6.27M | $775,133 | $549,755 | $55,434 | $5,469 |
| Receivables | $209,047 | $317,455 | $427,433 | $0 | — |
| Inventory | $620,768 | $324,657 | $230,197 | $114,645 | $0 |
| Current assets | $7.42M | $1.62M | $1.22M | $170,319 | $5,469 |
| PP&E, net | $630,279 | $111,374 | $7,299 | $4,547 | $291,438 |
| Intangibles | $5.33M | $3.70M | $3.95M | $4.20M | $33,324 |
| Total assets | $14.18M | $5.48M | $5.30M | $4.41M | $330,231 |
| Current liabilities | $2.17M | $2.16M | $1.62M | $1.06M | $383,090 |
| Short-term debt | — | $96,849 | $0 | — | — |
| Long-term debt | — | $0 | — | — | — |
| Total debt | — | $96,849 | — | — | — |
| Total liabilities | $2.92M | $2.16M | $1.67M | $1.06M | $383,090 |
| Shareholders' equity | $11.26M | $3.32M | $3.64M | $3.35M | -$52,859 |
| Net debt | — | -$678,284 | — | — | — |
| Shares outstanding | 18.52M | 6.14M | 97.55M | 93.95M | 22.95M |
| Cash flow statement | |||||
| Operating cash flow | -$5.87M | -$1.94M | -$1.21M | -$708,450 | -$24,206 |
| Capital expenditure | $193,953 | $0 | $4,015 | $5,350 | $0 |
| Free cash flow | -$6.06M | -$1.94M | -$1.22M | -$713,800 | -$24,206 |
| Investing cash flow | -$293,953 | $0 | -$4,015 | -$5,349 | -$287,100 |
| Financing cash flow | $11.66M | $2.16M | $1.71M | $763,764 | $316,775 |
| Depreciation & amortization | $329,334 | $264,696 | $248,510 | $15,862 | $9,737 |
| Stock-based compensation | $19.14M | $3.06M | $8.97M | $2.10M | $0 |
Free plan shows the latest 5 periods; Pro shows all 7 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.